Arkolith/Insider Trading/IRWD/Form 4

MCCOURT Thomas A

Chief Executive Officer, DirectorIRONWOOD PHARMACEUTICALS INC (IRWD) · full profile →Form 4 · filed Feb 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$740K
Net Open-Market Flow
-$740K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Sell(S)104K$3.66$379K1.5M
Feb 23, 2026Sell(S)95K$3.81$361K1.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-071496) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML